Plasma pteridine concentrations in patients with chronic renal failure

被引:34
|
作者
Yokoyama, K
Tajima, M
Yoshida, H
Nakayama, M
Tokutome, G
Sakagami, H
Hosoya, T
机构
[1] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Minato Ku, Tokyo 1058471, Japan
[2] Meikai Univ, Sch Dent, Dept Dent Pharmacol, Sakado, Saitama 35002, Japan
关键词
chronic renal failure; dihydrobiopterin; NADH; nitric oxide; superoxide; tetrabiopterin;
D O I
10.1093/ndt/17.6.1032
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Pteridine metabolism is impaired in the uraemic state. This may affect cardiovascular function and contribute to malnutrition. We wished to clarify further the impact of impaired pteridine metabolism. Methods. Using the HPLC method, the plasma concentrations of endogenous pteridines were determined in 64 patients with chronic renal failure (33 on intermittent haemodialysis (HD) treatment vs 31 not yet on renal replacement therapy), and in 18 healthy controls. The patients were classified into three groups on the basis of creatinine clearance (Ccr): group (a), Ccr >60 ml/min; group (b), Ccr=10-60 ml/min; group (c), all patients receiving HD. Results. Total neopterin (NP) and biopterin (BP) levels and the NP/BP ratio (a biomarker for macrophage activity) were significantly higher, whereas tetrahydrobiopterin (BH4)/dihydrobiopterin (BH2) ratio (a biomarker for nitric oxide synthase and phenylalanine hydroxylase activities) was significantly lower in, group (c) (118.9+/-11.7 ng/ml, 18.8+/-1.2 ng/ml, 6.79+/-0.53, and 0.26+/-0.06) than in healthy subjects (5.17+/-0.29 ng/ml, 2.83+/-0.19 ng/ml, 1.92+/-0.13, and 1.15+/-0.11; P<0.01). These significant differences were also observed between control and group (b) (12.4+/-2.20 ng/ml, 4.48+/-0.36 ng/ml, 2.81+/-0.48, and 0.74+/-0.08; P<0.01). In groups (a) and (b), significant negative correlations were found between Ccr and the total NP level (r=-0.663, P<0.01), the total BP level (r=-0.492, P<0.01), the BH2 level (r=-0.677, P<0.01), and the NP/BP ratio (r=0.493, P<0.01). Conversely, significant positive correlations were found-between Ccr and the BH4/BH2, ratio (r=0.602, P<0.01). Conclusion. The reduction of quinoid-type BH2 to BH4 is modified in patients with advanced chronic renal failure, before and after the initiation of regular HD treatment. These metabolic alterations may play a role in the impaired macrophage, endothelial constitutive nitric oxide synthase, or phenylalanine hydroxylase (PH) activities observed in such patients.
引用
收藏
页码:1032 / 1036
页数:5
相关论文
共 50 条
  • [21] Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis
    Iglesias, P
    Díez, JJ
    Fernández-Reyes, MJ
    Codoceo, R
    Alvarez-Fidalgo, P
    Bajo, MA
    Aguilera, A
    Selgas, R
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (01) : 68 - 73
  • [22] SERUM CONCENTRATIONS AND URINARY EXCRETION OF CEPHALOTIN IN PATIENTS WITH CHRONIC RENAL FAILURE
    EGETMEYER, A
    TOURKANTONIS, A
    MOSSNER, G
    HEINZE, V
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1971, 96 (12) : 494 - +
  • [23] Plasma adiponectin concentrations in patients with chronic renal failure: Relationship with metabolic risk factors and ischemic heart disease
    Tentolouris, N
    Doulgerakis, D
    Moyssakis, I
    Kyriaki, D
    Makrilakis, K
    Kosmadakis, G
    Stamatiadis, D
    Katsilambros, N
    Stathakis, C
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (10) : 721 - 727
  • [24] Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients
    Slow, S
    McGregor, DO
    Lever, M
    Lee, MB
    George, PM
    Chambers, ST
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (11) : 974 - 976
  • [25] TRACE-ELEMENT CONCENTRATIONS IN HAIR, FINGERNAILS AND PLASMA OF PATIENTS WITH CHRONIC-RENAL-FAILURE ON HEMODIALYSIS AND HEMOFILTRATION
    MARUMO, F
    TSUKAMOTO, Y
    IWANAMI, S
    KISHIMOTO, T
    YAMAGAMI, S
    [J]. NEPHRON, 1984, 38 (04): : 267 - 272
  • [26] The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients
    Hirata, Kenshiro
    Ikeda, Tokunori
    Watanabe, Hiroshi
    Maruyama, Toru
    Tanaka, Motoko
    Chuang, Victor Tuan Giam
    Uchida, Yuji
    Sakurama, Keiki
    Nishi, Koji
    Yamasaki, Keishi
    Otagiri, Masaki
    [J]. TOXINS, 2021, 13 (11)
  • [27] PLASMA-LIPIDS IN PATIENTS WITH CHRONIC RENAL-FAILURE
    KAYE, JP
    MOORHEAD, JF
    WILLS, MR
    [J]. CLINICA CHIMICA ACTA, 1973, 44 (03) : 301 - 305
  • [28] HETEROGENEITY OF PLASMA MOTILIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    SHIMA, K
    SHIN, S
    TANAKA, A
    HASHIMURA, E
    NISHINO, T
    IMAGAWA, K
    KUMAHARA, Y
    YANAIHARA, N
    [J]. HORMONE AND METABOLIC RESEARCH, 1980, 12 (07) : 328 - 331
  • [29] PLASMA ERYTHROPOIETIN ASSAY IN PATIENTS WITH CHRONIC RENAL-FAILURE
    DAVIES, S
    GLYNNEJONES, E
    BISSON, M
    BISSON, P
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1975, 28 (11) : 875 - 878
  • [30] Plasma Ceruloplasmin in Chronic Renal Failure Patients Undergoing Haemodialysis
    Ashok, K. J.
    Sajida, M. P.
    Joseph, S.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2010, 4 (01) : 2058 - 2060